Enhancing meningioma resection: a comprehensive study on the safety and effectiveness of Onyx™ presurgical embolization

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorBATISTA, Savio
dc.contributor.authorANDREAO, Filipi Fim
dc.contributor.authorPALAVANI, Lucca B.
dc.contributor.authorBORGES, Pedro
dc.contributor.authorVERLY, Gabriel
dc.contributor.authorBERTANI, Raphael
dc.contributor.authorFILHO, Jose Alberto Almeida
dc.contributor.authorPAIVA, Wellingson S.
dc.contributor.authorABREU, Livia V. de
dc.contributor.authorPESSOA, Bruno L.
dc.date.accessioned2023-12-15T19:02:21Z
dc.date.available2023-12-15T19:02:21Z
dc.date.issued2023
dc.description.abstractPresurgical embolization (PE) has emerged as an interesting strategy to help turn brain tumor resection more amenable. This study aims to systematically review the safety and effectiveness of Onyx (TM) PE in meningioma resection. We followed Cochrane Collaboration and PRISMA for systematic review and meta-analysis, querying PUBMED, Cochrane Library, Web of Science, and Embase databases. Major complications were defined as other artery occlusion, visual deficits due to PE, or non temporary nerve damage, while minor included transitory conditions and others without clinical implications. A total of 186 patients were included, in which 120 were WHO grade I (80%), II (16%), and III (4%). Patient baseline characteristics and complications were distributed in groups without or with individual patient data analysis. Individual Patient Data Meta-Analysis (IPDMA) was performed on the last category, comprising 51 meningiomas that underwent Onyx (TM) PE. Among available data, 70%, 17%, and 13% were WHO grade I, II, and III, respectively. Considering all studies, tumor characteristics regarding grade underscored a certain homogeneity. Complications occurred at a rate of 9% (95% CI, 4 to 14%; I2 = 35%), with the rate of major complications significantly lower at only 1% (95% CI, 0 to 3%; I2 = 32%), whereas of minor complications was 7% (95% CI, 3 to 10%; I2 = 0%). Mean surgery blood loss was 668.7 (95% CI, 534.9 to 835.8; I2 = 0%) in IPDMA. Onyx (TM) PE is promising for safer surgical meningioma resection, despite limitations. Further studies are required to validate efficacy, enhance patient selection, and refine techniques.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.identifier.citationNEUROSURGICAL REVIEW, v.46, n.1, article ID 299, 11p, 2023
dc.identifier.doi10.1007/s10143-023-02200-3
dc.identifier.eissn1437-2320
dc.identifier.issn0344-5607
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/57689
dc.language.isoeng
dc.publisherSPRINGEReng
dc.relation.ispartofNeurosurgical Review
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright SPRINGEReng
dc.subjectMeningiomaeng
dc.subjectOnyxeng
dc.subjectEVOHeng
dc.subjectPresurgicaleng
dc.subjectEmbolizationeng
dc.subject.othervinyl alcohol copolymereng
dc.subject.otherpreoperative embolizationeng
dc.subject.otherendovascular embolizationeng
dc.subject.othertechnical considerationseng
dc.subject.otherneckeng
dc.subject.otherheadeng
dc.subject.otherefficacyeng
dc.subject.otherutilityeng
dc.subject.othertumorseng
dc.subject.wosClinical Neurologyeng
dc.subject.wosSurgeryeng
dc.titleEnhancing meningioma resection: a comprehensive study on the safety and effectiveness of Onyx™ presurgical embolizationeng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalBATISTA, Savio:Univ Fed Rio de Janeiro, Fac Med, Av Carlos Chagas Filho,373 Ilha do, BR-21941902 Fundao, RJ, Brazil
hcfmusp.author.externalANDREAO, Filipi Fim:Univ Fed Rio de Janeiro, Fac Med, Av Carlos Chagas Filho,373 Ilha do, BR-21941902 Fundao, RJ, Brazil
hcfmusp.author.externalPALAVANI, Lucca B.:Max Planck Univ Ctr, Indaiatuba, SP, Brazil
hcfmusp.author.externalBORGES, Pedro:Fundacao Tecn Educ Souza Marques, Fac Med, Dept Pediat, Rio De Janeiro, Brazil
hcfmusp.author.externalVERLY, Gabriel:Univ Fed Rio de Janeiro, Fac Med, Av Carlos Chagas Filho,373 Ilha do, BR-21941902 Fundao, RJ, Brazil
hcfmusp.author.externalFILHO, Jose Alberto Almeida:Hosp Municipal Miguel Couto, Dept Neurosurg, Rio De Janeiro, Brazil
hcfmusp.author.externalABREU, Livia V. de:Univ Fed Rio de Janeiro, Fac Med, Av Carlos Chagas Filho,373 Ilha do, BR-21941902 Fundao, RJ, Brazil
hcfmusp.author.externalPESSOA, Bruno L.:Fed Fluminense Univ, Dept Neurosurg, Rio De Janeiro, Brazil
hcfmusp.citation.scopus2
hcfmusp.contributor.author-fmusphcRAPHAEL BERTANI DE MAGALHAES
hcfmusp.contributor.author-fmusphcWELLINGSON SILVA PAIVA
hcfmusp.description.articlenumber299
hcfmusp.description.issue1
hcfmusp.description.volume46
hcfmusp.origemWOS
hcfmusp.origem.pubmed37964033
hcfmusp.origem.scopus2-s2.0-85176457189
hcfmusp.origem.wosWOS:001101273100001
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUNITED STATESeng
hcfmusp.relation.referenceAlmefty RO, 2017, WORLD NEUROSURG, V102, P157, DOI 10.1016/j.wneu.2017.02.092eng
hcfmusp.relation.referenceBendszus M, 2000, NEUROSURGERY, V47, P1306, DOI 10.1097/00006123-200012000-00008eng
hcfmusp.relation.referenceDEAN BL, 1994, AM J NEURORADIOL, V15, P1675eng
hcfmusp.relation.referenceDubel GJ, 2013, SEMIN INTERVENT RAD, V30, P263, DOI 10.1055/s-0033-1353479eng
hcfmusp.relation.referenceElhammady MS, 2012, WORLD NEUROSURG, V77, P725, DOI 10.1016/j.wneu.2011.02.033eng
hcfmusp.relation.referenceElhammady MS, 2010, J NEUROSURG, V112, P1039, DOI 10.3171/2009.7.JNS09351eng
hcfmusp.relation.referenceFelbaum DR, 2016, CUREUS J MED SCIENCE, V8, DOI 10.7759/cureus.776eng
hcfmusp.relation.referenceFriconnet G, 2020, J NEURORADIOLOGY, V47, P355, DOI 10.1016/j.neurad.2019.05.012eng
hcfmusp.relation.referenceFusco Matthew R, 2016, J Cerebrovasc Endovasc Neurosurg, V18, P12, DOI 10.7461/jcen.2016.18.1.12eng
hcfmusp.relation.referenceGobin YP, 2001, RADIOLOGY, V221, P309, DOI 10.1148/radiol.2212001140eng
hcfmusp.relation.referenceGore P, 2008, NEUROSURGERY, V62, P1204, DOI 10.1227/01.neu.0000333292.74986.aceng
hcfmusp.relation.referenceGrandhi R, 2015, J NEUROL SURG PART A, V76, P309, DOI 10.1055/s-0034-1394191eng
hcfmusp.relation.referenceGuimaraes Marcelo, 2011, Semin Intervent Radiol, V28, P350, DOI 10.1055/s-0031-1284462eng
hcfmusp.relation.referenceIerardi Anna Maria, 2020, Acta Biomed, V91, P71, DOI 10.23750/abm.v91i8-S.9974eng
hcfmusp.relation.referenceJack AS, 2016, CAN J NEUROL SCI, V43, P206, DOI 10.1017/cjn.2015.264eng
hcfmusp.relation.referenceJames RF, 2016, NEUROSURG CLIN N AM, V27, P155, DOI 10.1016/j.nec.2015.11.005eng
hcfmusp.relation.referenceKerim AA, 2010, J NEUROSURG, V112, P70, DOI 10.3171/2008.11.JNS08175eng
hcfmusp.relation.referenceKominami S, 2012, INTERV NEURORADIOL, V18, P133, DOI 10.1177/159101991201800202eng
hcfmusp.relation.referenceLacobucci M, 2017, DIAGN INTERV IMAG, V98, P307, DOI 10.1016/j.diii.2016.08.006eng
hcfmusp.relation.referencePrzybylowski CJ, 2021, J NEUROSURG, V134, P693, DOI 10.3171/2020.1.JNS19788eng
hcfmusp.relation.referencePrzybylowski CJ, 2018, WORLD NEUROSURG, V116, pE371, DOI 10.1016/j.wneu.2018.04.208eng
hcfmusp.relation.referenceRangel-Castilla L, 2014, J NEUROINTERV SURG, V6, P51, DOI 10.1136/neurintsurg-2012-010542eng
hcfmusp.relation.referenceRaper DMS, 2014, AM J NEURORADIOL, V35, P1798, DOI 10.3174/ajnr.A3919eng
hcfmusp.relation.referenceRossitti S, 2007, ACTA RADIOL, V48, P321, DOI 10.1080/02841850601161547eng
hcfmusp.relation.referenceShah AH, 2013, J NEUROSURG, V119, P364, DOI 10.3171/2013.3.JNS121328eng
hcfmusp.relation.referenceShi ZS, 2008, SURG NEUROL, V70, P478, DOI 10.1016/j.surneu.2007.05.031eng
hcfmusp.relation.referenceSiekmann R, 2005, INTERV NEURORADIOL, V11, P131, DOI 10.1177/15910199050110S117eng
hcfmusp.relation.referenceSilva MA, 2020, NEUROCIRUGIA, V31, P173, DOI 10.1016/j.neucir.2019.10.003eng
hcfmusp.relation.referenceSpiotta AM, 2014, J NEUROINTERV SURG, V6, P547, DOI 10.1136/neurintsurg-2013-010833eng
hcfmusp.relation.referenceTorres G, 2019, J NEURO-OPHTHALMOL, V39, P520, DOI 10.1097/WNO.0000000000000772eng
hcfmusp.relation.referenceTrivelatto F, 2011, AM J NEURORADIOL, V32, P1762, DOI 10.3174/ajnr.A2591eng
hcfmusp.relation.referenceVelez AM, 2011, NEUROSURGERY, V68, pE1165, DOI 10.1227/NEU.0b013e31820a181aeng
hcfmusp.relation.referenceWen LL, 2017, J NEUROINTERV SURG, V9, P1139, DOI 10.1136/neurintsurg-2016-012658eng
hcfmusp.relation.referenceYounes S, 2022, CAN J OPHTHALMOL, V57, pE136, DOI 10.1016/j.jcjo.2021.12.001eng
hcfmusp.relation.referenceZacharewski Nicholas, 2022, J Neurol Surg Rep, V83, pe44, DOI 10.1055/s-0042-1749215eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationa107ada8-1497-4f10-b67d-90e4a321b1f0
relation.isAuthorOfPublicationb0c9118e-a4e8-4a25-91f1-ed0445ced2bd
relation.isAuthorOfPublication.latestForDiscoverya107ada8-1497-4f10-b67d-90e4a321b1f0
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_BATISTA_Enhancing_meningioma_resection_a_comprehensive_study_on_the_2023.PDF
Tamanho:
873.34 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)